---
figid: PMC2669548__nihms101177f1
figlink: /pmc/articles/PMC2669548/figure/F1/
number: Fig. 1
caption: A generalized schematic presentation of signaling pathways targeted by molecular
  therapies in malignant glioma. Receptor tyrosine kinases (RTKs) are shown in their
  activated (dimerized) form, binding ligand. The diagram illustrates pathways that
  are activated upon receptor activation. Many receptors share common intracellular
  effectors (i.e. Ras, AKT, protein kinase C [PKC], etc.) and no single intracellular
  pathway is exclusive to a particular receptor. Arrowheads indicate the activation
  of an intracellular molecule and/or a cellular response. A line with a blunted end
  corresponds to the inhibition of a cellular molecule and/or signaling pathway. As
  shown, molecular therapies have been designed to inhibit signaling pathways at different
  stages of the cellular response. Some therapies, such as bevacizumab, target angiogenesis
  at the level of the receptor by antagonizing VEGF-VEGFR interactions. Others, such
  as temsirolimus, target effectors (mTOR) that are downstream in a cellular response.
  AKT is a serine/threonine protein kinase (also known as protein kinase B [PKB])
  with pleiotropic effects on cell survival and growth. Raf is a serine/threonine
  protein kinase with pleiotropic effects on cell survival, differentiation, and proliferation.
  Ras is a small G protein, ‘a GTPase’, which acts as a second messenger by catalyzing
  the hydrolysis of GTP to guanosine diphosphate. EGFR =epidermal growth factor receptor;
  ERK =extracellular regulated kinase (also known as mitogen activated protein kinase
  [MAPK]); FT =farnesyltransferase; GTP =guanosine tripho-sphate; MEK =MAP-ERK kinase;
  mTOR =mammalian target of rapamycin; PDGFR =platelet-derived growth factor receptor;
  PI3K =phosphoinositide-3-kinase; PIP2 =phosphatidylinositol-4,5-biphosphate; PIP3
  =phosphatidylinositol-3,4,5-triphosphate; PTEN =phosphatase and tensin homologue
  deleted on chromosome 10; VEGF =vascular endothelial growth factor; VEGFR =vascular
  endothelial growth factor receptor.
pmcid: PMC2669548
papertitle: Targeted Therapies for Malignant Glioma.
reftext: Ronald W. Mercer, et al. BioDrugs. ;23(1):25-35.
pmc_ranked_result_index: '99246'
pathway_score: 0.9065219
filename: nihms101177f1.jpg
figtitle: Generalized schematic presentation of signaling pathways targeted by molecular
  therapies in malignant glioma
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2669548__nihms101177f1.html
  '@type': Dataset
  description: A generalized schematic presentation of signaling pathways targeted
    by molecular therapies in malignant glioma. Receptor tyrosine kinases (RTKs) are
    shown in their activated (dimerized) form, binding ligand. The diagram illustrates
    pathways that are activated upon receptor activation. Many receptors share common
    intracellular effectors (i.e. Ras, AKT, protein kinase C [PKC], etc.) and no single
    intracellular pathway is exclusive to a particular receptor. Arrowheads indicate
    the activation of an intracellular molecule and/or a cellular response. A line
    with a blunted end corresponds to the inhibition of a cellular molecule and/or
    signaling pathway. As shown, molecular therapies have been designed to inhibit
    signaling pathways at different stages of the cellular response. Some therapies,
    such as bevacizumab, target angiogenesis at the level of the receptor by antagonizing
    VEGF-VEGFR interactions. Others, such as temsirolimus, target effectors (mTOR)
    that are downstream in a cellular response. AKT is a serine/threonine protein
    kinase (also known as protein kinase B [PKB]) with pleiotropic effects on cell
    survival and growth. Raf is a serine/threonine protein kinase with pleiotropic
    effects on cell survival, differentiation, and proliferation. Ras is a small G
    protein, ‘a GTPase’, which acts as a second messenger by catalyzing the hydrolysis
    of GTP to guanosine diphosphate. EGFR =epidermal growth factor receptor; ERK =extracellular
    regulated kinase (also known as mitogen activated protein kinase [MAPK]); FT =farnesyltransferase;
    GTP =guanosine tripho-sphate; MEK =MAP-ERK kinase; mTOR =mammalian target of rapamycin;
    PDGFR =platelet-derived growth factor receptor; PI3K =phosphoinositide-3-kinase;
    PIP2 =phosphatidylinositol-4,5-biphosphate; PIP3 =phosphatidylinositol-3,4,5-triphosphate;
    PTEN =phosphatase and tensin homologue deleted on chromosome 10; VEGF =vascular
    endothelial growth factor; VEGFR =vascular endothelial growth factor receptor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3CB
  - PIK3R3
  - PRKCG
  - PIK3R6
  - PRKD3
  - KRAS
  - PRKCE
  - HRAS
  - PTEN
  - PIK3R4
  - PRKCI
  - PIK3CA
  - NRAS
  - ARAF
  - PRKCD
  - PRKCQ
  - PDGFRB
  - PIK3R5
  - MAPK1
  - PRKCB
  - MTOR
  - FLT4
  - MAP2K2
  - MAPK3
  - VEGFD
  - PDGFRA
  - KDR
  - PRKCA
  - MAP2K1
  - PGF
  - PRKCZ
  - VEGFA
  - BRAF
  - EGFR
  - VEGFC
  - AKT3
  - PIK3CG
  - PRKCH
  - VEGFB
  - FLT1
  - RAF1
  - AKT2
  - PIK3CD
  - AKT1
  - Rottlerin
  - Lonafarnib
  - Temsirolimus
  - Tipifarnib
  - Enzastaurin
  - Tamoxifen
  - rapamycin
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: Raf/MEK/ERK
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: PDGFR
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRB
  entrez: '5159'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: Raf/MEK/ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT4
  entrez: '2324'
- word: Raf/MEK/ERK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: Raf/MEK/ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: PDGFR
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRA
  entrez: '5156'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: Raf/MEK/ERK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: Raf/MEK/ERK
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT1
  entrez: '2321'
- word: Raf/MEK/ERK
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
chemicals:
- word: Rottlerin
  source: MESH
  identifier: C085746
- word: Lonafarnib
  source: MESH
  identifier: C115354
- word: Temsirolimus
  source: MESH
  identifier: C401859
- word: Tipifarnib
  source: MESH
  identifier: C402769
- word: Enzastaurin
  source: MESH
  identifier: C504878
- word: Tamoxifen
  source: MESH
  identifier: D013629
- word: rapamycin
  source: MESH
  identifier: D020123
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
